Search
forResearch 10 of 1000+
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Sequential Immunotherapy with Tofacitinib and Low-Dose IL-2 Induces Sustained Remission in Alopecia Areata: A Proof-of-concept monocentric study
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Alopecia Areata: Current Treatments and New Directions
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Alopecia Areata and Alopecia Areata Incognita
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- The potential of regulatory T cell-based therapies for alopecia areata
- Regulatory T Cells: the Many Faces of Foxp3
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
Community 10 of 504
- Surprising dutasteride studies on low dose effect
- Early impressions Rootique Dou + Ulo low dose finasteride
- Low dose finestaride 6 month progress (0,25mg)
- Japan Uses Low Dose Dutasteride (0.1mg). Minimal exposure and hair growth success.
- Low Dose Dutasteride Stops Hair Loss: 2-3x a Week Use.
- Low Dose Naltrexone For Inflammatory Hair Loss
- Low dose spiro with 5ARI inhibitor
- Low-Dose Oral Minoxidil Does Not Significantly Affect BP
- Low dose of fin 2x per week after stopping 1mg daily
- Do high dose topical Finasteride solutions offer any tangible advantages over low dose topical Finasteride solutions?